Vitamin D and non-Hodgkin lymphoma risk in adults: a review

Cancer Invest. 2009 Nov;27(9):942-51. doi: 10.3109/07357900902849632.

Abstract

Animal and human studies support a protective effect of vitamin D sufficiency related to malignancy by uncovering paracrine and autocrine effects of extra-renal 25-hydroxyvitamin D (25(OH)D) activation including regulation of cell cycle proliferation, apoptosis induction, and increased cell differentiation signaling. Recent epidemiologic studies demonstrate a reduction in non-Hodgkin lymphoma (NHL) risk with increased sunlight exposure. As sunlight is a major vitamin D source, it has been suggested that vitamin D status may mediate this observed association. This review provides a comprehensive discussion of the current epidemiologic evidence with regard to the investigation of an association between vitamin D status and NHL risk.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Calcifediol / metabolism
  • Dietary Supplements
  • Dihydroxycholecalciferols
  • Evidence-Based Medicine
  • Humans
  • Lymphoma, Non-Hodgkin / etiology*
  • Lymphoma, Non-Hodgkin / metabolism
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / prevention & control
  • Nutrition Policy
  • Risk Assessment
  • Risk Factors
  • Seasons
  • Signal Transduction
  • Ultraviolet Rays* / adverse effects
  • Vitamin D / administration & dosage
  • Vitamin D / metabolism*
  • Vitamin D Deficiency / complications*
  • Vitamin D Deficiency / metabolism

Substances

  • Dihydroxycholecalciferols
  • Vitamin D
  • Calcifediol